Efficacy of vagus nerve stimulation for drug-resistant epilepsy in children age six and younger.

This study demonstrates the safety and efficacy of VNS for children with drug-resistant epilepsy (DRE) younger than six. One, two, and four years after VNS implantation, 55%, 60%, and 52% of these patients, respectively, achieved ≥50% reduction in seizure frequency. The safety of VNS is also comparable with older, better studied, age groups. Based on these data, VNS therapy should be considered for children younger than six. PMID: 32942207 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32942207?dopt=Abstract

Source: Epilepsy and Behaviour - September 13, 2020 Category: Neurology Authors: Muthiah N, Zhang J, Remick M, Welch W, Sogawa Y, Jeong JH, Abel TJ Tags: Epilepsy Behav Source Type: research